Report Detail
Global (United States, European Union and China) Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Research Report 2019-2025
- RnM3675344 |
- 16 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Dipeptide Peptidase 4 (DPP-4) Inhibitors are a class of oral diabetes drugs that work by blocking the action of DPP-4, an enzyme which destroys a group of gastrointestinal hormones called incretins. Incretins help stimulate the production of insulin when it is needed (e.g. after eating) and reduce the production of glucagon by the liver when it is not needed (e.g. during digestion). They also slow down digestion and decrease appetite. So by protecting incretins from damage, DPP-4 inhibitors help regulate blood glucose levels.
Januvia (Sitagliptin), Galvus (Vildagliptin), Onglyza (Saxagliptin), Tradjenta (Linagliptin) are the major DPP-4 drugs in the market.
In 2019, the market size of Dipeptide Peptidase 4 (DPP-4) Inhibitors is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dipeptide Peptidase 4 (DPP-4) Inhibitors.
This report studies the global market size of Dipeptide Peptidase 4 (DPP-4) Inhibitors, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Dipeptide Peptidase 4 (DPP-4) Inhibitors sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Merck
Eli Lilly
AstraZenica
Boehringer Ingelheim
Takeda Pharmaceutical Company
BMS
...
Market Segment by Product Type
Sitagliptin
Saxagliptin
Linagliptin
Alogliptin
Vildagliptin
Market Segment by Application
Hospitals
Clinics
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Dipeptide Peptidase 4 (DPP-4) Inhibitors status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Dipeptide Peptidase 4 (DPP-4) Inhibitors manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Dipeptide Peptidase 4 (DPP-4) Inhibitors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Sitagliptin
- 1.3.3 Saxagliptin
- 1.3.4 Linagliptin
- 1.3.5 Alogliptin
- 1.3.6 Vildagliptin
- 1.4 Market Segment by Application
- 1.4.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size
- 2.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue 2014-2025
- 2.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales 2014-2025
- 2.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Growth Rate by Regions
- 2.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Regions 2014-2019
- 2.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Manufacturers
- 3.1.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Manufacturers 2014-2019
- 3.1.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Manufacturers (2014-2019)
- 3.2.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Concentration Ratio (CR5 and HHI)
- 3.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Manufacturers
- 3.4 Key Manufacturers Dipeptide Peptidase 4 (DPP-4) Inhibitors Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- 3.6 Key Manufacturers Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Sitagliptin Sales and Revenue (2014-2019)
- 4.1.2 Saxagliptin Sales and Revenue (2014-2019)
- 4.1.3 Linagliptin Sales and Revenue (2014-2019)
- 4.1.4 Alogliptin Sales and Revenue (2014-2019)
- 4.1.5 Vildagliptin Sales and Revenue (2014-2019)
- 4.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type
- 4.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Type
- 4.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application
6 United States
- 6.1 United States Dipeptide Peptidase 4 (DPP-4) Inhibitors Breakdown Data by Company
- 6.2 United States Dipeptide Peptidase 4 (DPP-4) Inhibitors Breakdown Data by Type
- 6.3 United States Dipeptide Peptidase 4 (DPP-4) Inhibitors Breakdown Data by Application
7 European Union
- 7.1 European Union Dipeptide Peptidase 4 (DPP-4) Inhibitors Breakdown Data by Company
- 7.2 European Union Dipeptide Peptidase 4 (DPP-4) Inhibitors Breakdown Data by Type
- 7.3 European Union Dipeptide Peptidase 4 (DPP-4) Inhibitors Breakdown Data by Application
8 China
- 8.1 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Breakdown Data by Company
- 8.2 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Breakdown Data by Type
- 8.3 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Dipeptide Peptidase 4 (DPP-4) Inhibitors Breakdown Data by Company
- 9.2 Rest of World Dipeptide Peptidase 4 (DPP-4) Inhibitors Breakdown Data by Type
- 9.3 Rest of World Dipeptide Peptidase 4 (DPP-4) Inhibitors Breakdown Data by Application
- 9.4 Rest of World Dipeptide Peptidase 4 (DPP-4) Inhibitors Breakdown Data by Countries
- 9.4.1 Rest of World Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Countries
- 9.4.2 Rest of World Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Merck
- 10.1.1 Merck Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors
- 10.1.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Introduction
- 10.1.5 Merck Recent Development
- 10.2 Eli Lilly
- 10.2.1 Eli Lilly Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors
- 10.2.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Introduction
- 10.2.5 Eli Lilly Recent Development
- 10.3 AstraZenica
- 10.3.1 AstraZenica Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors
- 10.3.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Introduction
- 10.3.5 AstraZenica Recent Development
- 10.4 Boehringer Ingelheim
- 10.4.1 Boehringer Ingelheim Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors
- 10.4.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Introduction
- 10.4.5 Boehringer Ingelheim Recent Development
- 10.5 Takeda Pharmaceutical Company
- 10.5.1 Takeda Pharmaceutical Company Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors
- 10.5.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Introduction
- 10.5.5 Takeda Pharmaceutical Company Recent Development
- 10.6 BMS
- 10.6.1 BMS Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Dipeptide Peptidase 4 (DPP-4) Inhibitors
- 10.6.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Introduction
- 10.6.5 BMS Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Channels
- 11.2.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Distributors
- 11.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Customers
12 Market Forecast
- 12.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales and Revenue Forecast 2019-2025
- 12.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast by Type
- 12.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast by Application
- 12.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Forecast by Regions
- 12.4.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast by Regions 2019-2025
- 12.4.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Dipeptide Peptidase 4 (DPP-4) Inhibitors. Industry analysis & Market Report on Dipeptide Peptidase 4 (DPP-4) Inhibitors is a syndicated market report, published as Global (United States, European Union and China) Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Dipeptide Peptidase 4 (DPP-4) Inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
